Search | IOVS | ARVO Journals

Showing 1 – 20 of 78

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Visual function deficits in moderately-severe to severe non-proliferative diabetic retinopathy (NPDR) despite normal BCVA

Ulrich F O Luhmann; Jules Hernandez-Sanches; Fern Ellis; Luis A Lesmes; Michael Wall; Nikolaos Mitrousis; Claire Hippert; David Kent; Beatriz G. Armendariz; Andreas Wenzel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3831.

ARVO Annual Meeting Abstract June 2024

REVISION – Early Reperfusion Therapy with Alteplase for Recovery of Vision in Acute Central Retinal Artery Occlusion: A Phase III Double-Blind Randomized Placebo-Controlled Trial

Daniel A. Wenzel; Caroline J. Gassel; Sven Poli; Karl Ulrich Bartz-Schmidt; Spyridon Dimopoulos; Maximilian Schultheiss; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1738.

ARVO Annual Meeting Abstract June 2024

Long-Term Efficacy and Impact on Corneal Endothelial Cells of PRESERFLO® MicroShunt

Caroline Julia Gassel; Daniel A. Wenzel; Torsten Strasser; Karl Ulrich Bartz-Schmidt; Bogomil Voykov

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3510.

ARVO Annual Meeting Abstract June 2023

Expression profiles of potentially angio-modulative microRNAs in the mouse model of oxygen-induced retinopathy (OIR)

Martin Busch; Anna Wenzel; Johanna M Pfeil; Andreas Stahl

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1234.

ARVO Annual Meeting Abstract June 2022

Machine learning approach to identify future treatment requirement in pretreated nAMD patients based on OCT images

Ales Neubert; Andreas Maunz; Siqing Yu; Thu Le von Strauss; Andreas Wenzel; Jian Dai

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2991 – F0261.

ARVO Annual Meeting Abstract June 2021

Disease Progression and Treatment Patterns in Pediatric and Adult Patients with Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME) in the US, a Commercial Claims-Based Analysis

Shih-Chen Chang; Beatriz Garcia Armendariz; Anup Abraham; Priya Kulkarni; Ching-Yi Chuo; Andreas Wenzel

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1136.

ARVO Annual Meeting Abstract July 2019

Outcomes after Descemet Membrane Endothelial Keratoplasty (DMEK) in a German multicenter study

Klara Charlotte Borgardts; Kristina Spaniol; Björn Bachmann; Martin Hellmich; Gerd Geerling; Philip Maier; Peter MH Wiedemann; Karl Ulrich Bartz-Schmidt; Max Pattmoeller; Anna-Karina Maier-Wenzel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2224.

ARVO Annual Meeting Abstract September 2016

The effect of brolucizumab applied by microvolume injection or infusion in patients with neovascular age-related macular degeneration

Chirag Jhaveri; Andreas Wenzel; Andreas Weichselberger

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5061.

ARVO Annual Meeting Abstract June 2015

Baseline visual acuity predicts visual acuity gain in Patients with Diabetic Macular Edema Following Anti-VEGF Treatment

Jost Hillenkamp; Georg Spital; Andreas Wenzel; Philippe Margaron; Jessica Voegeler

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1768.

ARVO Annual Meeting Abstract June 2015

Efficacy of RTH258 (ESBA1008), an Anti-VEGF Agent, Applied by Microvolume Injection or Infusion in Subjects with Neovascular AMD

Brian B Berger; Susan E Yanni; Andreas Wenzel; Andreas Weichselberger; Jean Pierre Hubschman

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):821.

ARVO Annual Meeting Abstract April 2014

Optical Coherence Tomography Enables Imaging of Retinoblastoma Tumor Initiation in the TAg-RB Mouse Model

Andrea Wenzel; Mehdi Shadmand; Timothy William Corson

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3069.

ARVO Annual Meeting Abstract June 2013

Optical coherence tomography for screening of orthotopic retinoblastoma xenografts

Andrea Wenzel; Brian Samuels; Timothy Corson

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3967.

ARVO Annual Meeting Abstract June 2013

In vivo imaging and characterization of an orthotopic retinoblastoma xenograft model

Timothy Corson; Anna Geary; Andrea Wenzel; Amanda Riley; Brian McCarthy; Barbara Bailey; Karen Pollok; Paul Territo; Brian Samuels

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1253.

ARVO Annual Meeting Abstract April 2011

Deleterious Actions Of Vegf On The Blood Retinal Barrier And Photoreceptor Survival In The Light-damage Model

Maite Cachafeiro; Alexis-Pierre Bemelmans; Marijana Samardzija; Andreas Wenzel; Christian Grimm; Yvan Arsenijevic

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1848.

ARVO Annual Meeting Abstract April 2010

Diagnostic Challenges in Hereditary Retinal Degenerations With Very Low Levels of Vitamin A

M. W. Seeliger; M. D. Fischer; M. Samardzija; E. Fahl; C. E. Remé; C. Grimm; A. Wenzel; N. Tanimoto

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5568.

Retina December 2009

Spectral Domain Optical Coherence Tomography in Mouse Models of Retinal Degeneration

PDF

Gesine Huber; Susanne C. Beck; Christian Grimm; Ayse Sahaboglu-Tekgoz; Francois Paquet-Durand; Andreas Wenzel; Peter Humphries; T. Michael Redmond; Mathias W. Seeliger; M. Dominik Fischer
TAGS: histology, mice, optical coherence tomography, retinal degeneration, diagnostic imaging
Invest. Ophthalmol. Vis. Sci.. 2009; 50(12):5888-5895. https://doi.org/10.1167/iovs.09-3724

ARVO Annual Meeting Abstract April 2009

Increased Therapeutic Window for the R91W Mutant Form of Rpe65 Compared to Rpe65 Null Background

C. Kostic; A.-P. Bemelmans; S. Crippa; M. Samardzija; V. Pignat; M. Tekaya; D. Wanner; A. Wenzel; Y. Arsenijevic

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1743.

ARVO Annual Meeting Abstract April 2009

Novel Relationship Between Vegf Expression and Retinal Pigmented Epithelium Permeability Following Light Damage in the Mouse Retina

M. Cachafeiro; A.-P. Bemelmans; C. Kostic; M. Samardzija; M. Tekaya; D. Wanner; A. Wenzel; Y. Arsenijevic

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3524.

Retinal Cell Biology March 2009

Nonessential Role of β3 and β5 Integrin Subunits for Efficient Clearance of Cellular Debris after Light-Induced Photoreceptor Degeneration

PDF

Sandrine Joly; Marijana Samardzija; Andreas Wenzel; Markus Thiersch; Christian Grimm
TAGS: drug clearance, integrins, light exposure, mice, monocyte chemoattractant protein-1, photoreceptors, tissue degeneration, retina, macrophages, chemokines
Invest. Ophthalmol. Vis. Sci.. 2009; 50(3):1423-1432. https://doi.org/10.1167/iovs.08-2432

ARVO Annual Meeting Abstract May 2008

Laser-Induced Choroidal Neovascularization Model to Evaluate Anti-Vegf Gene Transfer Therapy

M. Cachafeiro; J. Pournaras; A. Bemelmans; C. Kostic; M. Tekaya; V. Pignat; D. Wanner; A. Wenzel; T. Afanasieva; Y. Arsenijevic

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):536.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Visual function deficits in moderately-severe to severe non-proliferative diabetic retinopathy (NPDR) despite normal BCVA

REVISION – Early Reperfusion Therapy with Alteplase for Recovery of Vision in Acute Central Retinal Artery Occlusion: A Phase III Double-Blind Randomized Placebo-Controlled Trial

Long-Term Efficacy and Impact on Corneal Endothelial Cells of PRESERFLO® MicroShunt

Expression profiles of potentially angio-modulative microRNAs in the mouse model of oxygen-induced retinopathy (OIR)

Machine learning approach to identify future treatment requirement in pretreated nAMD patients based on OCT images

Disease Progression and Treatment Patterns in Pediatric and Adult Patients with Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME) in the US, a Commercial Claims-Based Analysis

Outcomes after Descemet Membrane Endothelial Keratoplasty (DMEK) in a German multicenter study

The effect of brolucizumab applied by microvolume injection or infusion in patients with neovascular age-related macular degeneration

Baseline visual acuity predicts visual acuity gain in Patients with Diabetic Macular Edema Following Anti-VEGF Treatment

Efficacy of RTH258 (ESBA1008), an Anti-VEGF Agent, Applied by Microvolume Injection or Infusion in Subjects with Neovascular AMD

Optical Coherence Tomography Enables Imaging of Retinoblastoma Tumor Initiation in the TAg-RB Mouse Model

Optical coherence tomography for screening of orthotopic retinoblastoma xenografts

In vivo imaging and characterization of an orthotopic retinoblastoma xenograft model

Deleterious Actions Of Vegf On The Blood Retinal Barrier And Photoreceptor Survival In The Light-damage Model

Diagnostic Challenges in Hereditary Retinal Degenerations With Very Low Levels of Vitamin A

Spectral Domain Optical Coherence Tomography in Mouse Models of Retinal Degeneration

Increased Therapeutic Window for the R91W Mutant Form of Rpe65 Compared to Rpe65 Null Background

Novel Relationship Between Vegf Expression and Retinal Pigmented Epithelium Permeability Following Light Damage in the Mouse Retina

Nonessential Role of β3 and β5 Integrin Subunits for Efficient Clearance of Cellular Debris after Light-Induced Photoreceptor Degeneration

Laser-Induced Choroidal Neovascularization Model to Evaluate Anti-Vegf Gene Transfer Therapy

To View More...

You must be signed into an individual account to use this feature.